Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Large capital increase led to high volatility in the stock -
Tirlán sells €230m block in Glanbia to buy back bonds
-
Danish wind developer gets faster project restart than Equinor
-
Shares jump and Andel commits to take its share
-
Beleaguered developer picks syndicate for equity raise
-
Capital raise consequence of the Trump administration's onslaught on renewables
